Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue SUPPL. 3, 1999, Pages 737-744

  Bolli, Geremia B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Adolescents; Children; Hypoglycemia; Insulin analogues; Intensive insulin therapy

Indexed keywords

INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN;

CONFERENCE PAPER; DRUG EFFECT; DRUG MIXTURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MEAL;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; FOOD; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE;

EID: 0033457342     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Rizza RA, Gerich JE, Haymond MW, Westland R, Hall L, Clemens A, Service J. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional therapy. N Engl J Med 1980; 303: 1313-1318.
2. Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-309.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
4. Bolli GB. The pharmacokinetic basis of insulin therapy in diabetes mellitus. Diab Res Clin Pract 1989; 6: S3-S16.
5. 1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia. Diabetologia 1996; 39: 677-686.
6. Fanelli C, Pampanelli S, Epifano, L Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusanio F, Brunetti P, Bolli GB. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 1994; 37: 1265-1276.
7. Bott S, Bott U, Berger M, Mülhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997; 40: 926-932.
8. Mühlhauser I, Overmann H, Bender R, Bott U, Berger M. Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes - a prospective population based study. Diabetologia 1998; 41: 1274-1282.
9. Valle T, Koivisto VA, Reunanen A, Kangas T, Rissanen A. Glycemic control in patients with diabetes in Finland. Diabetes Care 1999; 22: 575-579.
10. Dimitriadis GD, Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983; 6: 374-377.
11. 1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. Diabetes Care 1999; 22: 795-800.
12. Bolli GB, Di Marchi RD, Park G, Pramming S, Koivisto VA. Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 1999; 42: 1151-1167.
13. Torlone E, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli GB. Effects of short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 1996; 19: 945-952.
14. Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB. Improved postprandial metabolic control after subcutaneous injection of a short acting insulin analogue in IDDM of short duration with residual pancreatic beta cell function. Diabetes Care 1995; 18: 1452-1459.
15. Del Sindaco P, Ciofetta M, Lalli C, Perriello G, Pampanelli S, Torlone E, Brunetti P, Bolli GB. Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabetic Med 1998; 15: 592-600.
16. Binder C, Lauritzen T, Faber O, Pramming S. Insulin pharmacokinetics. Diabetes Care 1984; 7: 188-199.
17. Lalli C, Ciofetta M, Del Sindaco P, Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, Cartechini MG, Bartocci L, Brunetti P, Bolli GB. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analogue lispro in variable combination with NPH insulin at mealtime. Diabetes Care 1999; 22: 468-477.
18. Bolli GB, Perriello G, Fanelli CG, De Feo P. Nocturnal blood glucose control in type 1 diabetes mellitus. Diabetes Care 1993; 16 (Suppl 3): 71-89.